CHF6001 (tanimilast)

tanimilast · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF6001 (tanimilast), covering 2024-03-18 to 2024-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects [Phase 1]